Home | Cancers | Lung Cancer

Lung Cancer

Comorbid Conditions Associated With Worse Lung Cancer Survival

PHILADELPHIA — Lung cancer patients with comorbid conditions such as chronic obstructive pulmonary disease, diabetes, or congestive heart failure had a higher ...

Comorbid conditions hurt lung cancer survival rates

by Lauren Riley, American Association for Cancer Research and Tom O'Connor, UNMC public relations ...

Wistar Scientists Discover “Highly Effective” New Biomarker for Lung Cancer

PHILADELPHIA—(June 3, 2015)—Survival rates for patients with lung cancer increase dramatically the earlier the disease is diagnosed, underscoring the need for effective biomarkers that can be used for detection. Now, scientists at The Wistar Institute have found a protein that circulates in the blood that appears to be more accurate at detecting non-small cell lung cancer (NSCLC) than currently available methods used for screening. ... Full story

Moffitt Cancer Center Researchers Report that MEDI4736 Combined with Tremelimumab Results in Acceptable Toxicity, Clinical Activity in Non-Small Cell Lung Cancer Patients

TAMPA, Fla. – Advanced non-small cell lung cancer (NSCLC) patients have few effective treatment options and low 5-year survival rates. ... Full story

Molecule Designed to Treat Lung Cancer Shows Promising Results in Mice

A multidisciplinary team led by Johns Hopkins researcher Venu Raman, Ph.D., with notable contributions from Guus Bol, Farhad Vesuna and Phuoc Tran of Johns Hopkins, has identified a new therapy for lung cancer, the most common cancer worldwide. ... Full story

Drug-resistant lung cancer may have Achilles heel

By Bill Hathaway - Drugs introduced more than a decade ago that target mutations in a protein known as the epidermal growth factor receptor (EGFR) held the promise of personalized treatments for a common form of non-small cell lung cancer. But most patients quickly develop resistance to these drugs and are left with few or no treatment options, because it has been very difficult to design new drugs that act selectively upon the drug-resistant form. ... Full story

Stereotactic Ablative Radiotherapy achieves better overall survival than surgery for early lung cancer

First randomized clinical trial comparing the two therapies suggests that the non-invasive SABR treatment should be considered an alternative to surgery, especially for elderly patients and those with comorbidities ... Full story

New ASTRO guideline on definitive and adjuvant radiation therapy for locally advanced non-small cell lung cancer, nearly one-quarter of all lung cancers, featured in May-June issue of PRO

The American Society for Radiation Oncology (ASTRO) is issuing a new guideline, “Definitive and adjuvant radiotherapy in locally advanced non-small cell lung cancer: An American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline.” The guideline’s executive summary is published in the May-June issue of Practical Radiation Oncology (PRO), ASTRO’s clinical practice journal. The complete guideline, which cites 35 years of data to help guide current treatment and future research, is available online as an open-access article in PRO. ... Full story

Profiling approach to enable right lung cancer treatment match

Manchester researchers have tested a new way to genetically profile lung cancer samples, potentially allowing doctors to more easily identify the most appropriate treatment for patients. ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 149 | displaying: 1 - 10